This finding is in line with the study of Elbasateeny et al., who reported that CD44 along with CD133 might participate in early-stage endometrial cancer carcinogenesis, and their overexpression might facilitate early diagnosis of endometrial cancers [9]. The gene discussed is CD44; the disease is endometrial cancer.